Nanjing Chia-tai Tianqing Pharmaceutical
Nanjing Chia-tai Tianqing Pharmaceutical
Explore linked clinical trials.11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Drug-Drug Interaction Study Between NTQ5082 Capsules and Midazolam Oral Solutio | Drug-Drug Interaction (DDI); Healthy Volunteers | Not yet recruiting | Phase 1 | 2026-08-04 | NCT07745439 | |
| An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-03-10 | NCT07462130 | |
| A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 3 | 2026-02-06 | NCT07393321 | |
| A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients | Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria | Active, not recruiting | Phase 2 | 2025-09-23 | NCT06764303 | |
| Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants | endocrine exophthalmos | Enrolling by invitation | Phase 1 | 2025-09-19 | NCT07182552 | |
| A Long-term Efficacy and Safety of NTQ5082 Capsules | Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria | Not yet recruiting | Phase 3 | 2025-09-17 | NCT07177872 | |
| A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients | Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria | Not yet recruiting | Phase 3 | 2025-09-17 | NCT07177859 | |
| Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Not yet recruiting | Phase 2 | 2025-05-21 | NCT06982040 | |
| Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Injection | Acute Normovolemic Hemodilution | Not yet recruiting | Not applicable | 2025-05-18 | NCT06977763 | |
| Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Electrolyte Sodium Acetate Injection | Acute Normovolemic Hemodilution | Recruiting | Not applicable | 2025-05-18 | NCT06977750 | |
| A Study of Ramelteon in Chinese Patients With Chronic Insomnia | Chronic Insomnia, Dyssomnias, Sleep Disorders, Intrinsic, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Not yet recruiting | Phase 3 | 2024-07-22 | NCT06512363 |